Bayer (1BAYN) Stock Forecast & Price Target

Compare

10 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1BAYN Analyst Ratings

Moderate Buy

6 Buy

3 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Bayer

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1BAYN Stock 12 Month Forecast

Average Price Target

€44.22

▲(11.89% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Bayer in the last 3 months. The average price target is €44.22 with a high forecast of €54.00 and a low forecast of €23.00. The average price target represents a 11.89% change from the last price of €39.52.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"€21","38":"€38","55":"€55","29.5":"€29.5","46.5":"€46.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":54,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€54.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€44.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,29.5,38,46.5,55],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.975,41.97692307692308,42.978846153846156,43.98076923076923,44.98269230769231,45.98461538461539,46.986538461538466,47.988461538461536,48.99038461538461,49.99230769230769,50.99423076923077,51.996153846153845,52.99807692307692,{"y":54,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.975,41.22461538461538,41.47423076923077,41.723846153846154,41.97346153846154,42.223076923076924,42.472692307692306,42.722307692307695,42.971923076923076,43.22153846153846,43.47115384615385,43.72076923076923,43.97038461538462,{"y":44.22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.975,39.59230769230769,38.20961538461538,36.82692307692308,35.44423076923077,34.06153846153846,32.67884615384615,31.296153846153846,29.91346153846154,28.53076923076923,27.14807692307692,25.765384615384615,24.382692307692306,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.681,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.223,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.045,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.14,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.46,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.145,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.955,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 49, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.46,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 60, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 78, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.84,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 66, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.975,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 67, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€54.00

Average Price Target€44.22

Lowest Price Target€23.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Charles Pitman CFA

Barclays

€48

Buy

21.46%

Upside

Reiterated

03/16/26

Barclays Sticks to Its Buy Rating for Bayer (0P6S)

Matthew Weston

UBS

€48→€52

Buy

31.58%

Upside

Upgraded

03/16/26

Bayer (0P6S) was upgraded to a Buy Rating at UBS

James Quigley

Goldman Sachs

€54

Buy

36.64%

Upside

Reiterated

03/16/26

Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)

Thibault Boutherin

Morgan Stanley

€55→€53

Buy

34.11%

Upside

Reiterated

03/11/26

Bayer price target lowered to EUR 53 from EUR 55 at Morgan StanleyBayer price target lowered to EUR 53 from EUR 55 at Morgan Stanley

Richard Vosser

J.P. Morgan

€50

Buy

26.52%

Upside

Reiterated

03/09/26

Bayer (0P6S) Gets a Buy from J.P. Morgan

Sebastian Bray

Berenberg Bank

€42.2→€40

Hold

1.21%

Upside

Reiterated

03/05/26

Bayer (0P6S) Gets a Hold from Berenberg Bank

Falko Friedrichs

Deutsche Bank

€23

Hold

-41.80%

Downside

Reiterated

03/05/26

Bayer (0P6S) Receives a Hold from Deutsche Bank

Christian Faitz

Kepler Capital

€53

Buy

34.11%

Upside

Reiterated

03/04/26

Kepler Capital Reaffirms Their Buy Rating on Bayer (0P6S)

Chris Counihan

Jefferies

€25

Hold

-36.74%

Downside

Reiterated

03/04/26

Jefferies Remains a Hold on Bayer (0P6S)

Peter Spengler

DZ BANK AG

―

Sell

―

Downgraded

02/18/26

DZ BANK AG downgrades Bayer (0P6S) to a Sell

Rajesh Kumar

HSBC

€34→€40

Buy

1.21%

Upside

Reiterated

12/10/25

Bayer price target raised to EUR 40 from EUR 34 at HSBCBayer price target raised to EUR 40 from EUR 34 at HSBC

Sachin Jain

Bank of America Securities

€35

Buy

-11.44%

Downside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Bayer (0P6S)

Florent Cespedes

Bernstein

€30

Hold

-24.09%

Downside

Reiterated

11/24/25

Bernstein Sticks to Its Hold Rating for Bayer (0P6S)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Charles Pitman CFA

Barclays

€48

Buy

21.46%

Upside

Reiterated

03/16/26

Barclays Sticks to Its Buy Rating for Bayer (0P6S)

Matthew Weston

UBS

€48→€52

Buy

31.58%

Upside

Upgraded

03/16/26

Bayer (0P6S) was upgraded to a Buy Rating at UBS

James Quigley

Goldman Sachs

€54

Buy

36.64%

Upside

Reiterated

03/16/26

Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)

Thibault Boutherin

Morgan Stanley

€55→€53

Buy

34.11%

Upside

Reiterated

03/11/26

Bayer price target lowered to EUR 53 from EUR 55 at Morgan StanleyBayer price target lowered to EUR 53 from EUR 55 at Morgan Stanley

Richard Vosser

J.P. Morgan

€50

Buy

26.52%

Upside

Reiterated

03/09/26

Bayer (0P6S) Gets a Buy from J.P. Morgan

Sebastian Bray

Berenberg Bank

€42.2→€40

Hold

1.21%

Upside

Reiterated

03/05/26

Bayer (0P6S) Gets a Hold from Berenberg Bank

Falko Friedrichs

Deutsche Bank

€23

Hold

-41.80%

Downside

Reiterated

03/05/26

Bayer (0P6S) Receives a Hold from Deutsche Bank

Christian Faitz

Kepler Capital

€53

Buy

34.11%

Upside

Reiterated

03/04/26

Kepler Capital Reaffirms Their Buy Rating on Bayer (0P6S)

Chris Counihan

Jefferies

€25

Hold

-36.74%

Downside

Reiterated

03/04/26

Jefferies Remains a Hold on Bayer (0P6S)

Peter Spengler

DZ BANK AG

―

Sell

―

Downgraded

02/18/26

DZ BANK AG downgrades Bayer (0P6S) to a Sell

Rajesh Kumar

HSBC

€34→€40

Buy

1.21%

Upside

Reiterated

12/10/25

Bayer price target raised to EUR 40 from EUR 34 at HSBCBayer price target raised to EUR 40 from EUR 34 at HSBC

Sachin Jain

Bank of America Securities

€35

Buy

-11.44%

Downside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Bayer (0P6S)

Florent Cespedes

Bernstein

€30

Hold

-24.09%

Downside

Reiterated

11/24/25

Bernstein Sticks to Its Hold Rating for Bayer (0P6S)

Stocks with the Highest Top Analyst Consensus in the General Sector

xxx

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bayer

3 Months

xxx

Success Rate

18/26 ratings generated profit

Average Return

+4.60%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +4.60% per trade.

1 Year

James QuigleyGoldman Sachs

Success Rate

18/26 ratings generated profit

Average Return

+10.92%

reiterated a buy rating 4 days ago

Copying James Quigley's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +10.92% per trade.

2 Years

xxx

Success Rate

18/26 ratings generated profit

Average Return

+8.93%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 69.23% of your transactions generating a profit, with an average return of +8.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1BAYN Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

101

100

In the current month, 1BAYN has received 29 Buy Ratings, 67 Hold Ratings, and 4 Sell Ratings. 1BAYN average Analyst price target in the past 3 months is 44.22.

Each month's total comprises the sum of three months' worth of ratings.

1BAYN Financial Forecast

1BAYN Earnings Forecast

Next quarter’s earnings estimate for 1BAYN is €2.22 with a range of €2.13 to €2.39. The previous quarter’s EPS was €0.62. 1BAYN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year 1BAYN has Performed in-line its overall industry.

1BAYN Sales Forecast

Next quarter’s sales forecast for 1BAYN is €13.51B with a range of €13.25B to €13.90B. The previous quarter’s sales results were €11.44B. 1BAYN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year 1BAYN has Performed in-line its overall industry.

1BAYN Stock Forecast FAQ

What is IT:1BAYN’s average 12-month price target, according to analysts?

Based on analyst ratings, Bayer’s 12-month average price target is 44.22.

What is IT:1BAYN’s upside potential, based on the analysts’ average price target?

Bayer has 11.89% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Bayer a Buy, Sell or Hold?

Bayer has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 3 hold ratings and 1 sell ratings.

What is Bayer’s share price target?

The average share price target for Bayer is 44.22. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €54.00 ,and the lowest forecast is €23.00. The average share price target represents 11.89% Increase from the current price of €39.52.

What do analysts say about Bayer?

Bayer’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Bayer?

To buy shares of IT:1BAYN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Bayer (1BAYN) Stock Forecast & Price Target

1BAYN Analyst Ratings

1BAYN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Bayer

1BAYN Analyst Recommendation Trends

1BAYN Financial Forecast

1BAYN Earnings Forecast

1BAYN Sales Forecast

1BAYN Stock Forecast FAQ

Detailed List of Analyst Forecasts